Cargando…

Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway

When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikhailov, Alexei, Shinohara, Mio, Rieder, Conly L.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172207/
https://www.ncbi.nlm.nih.gov/pubmed/15302851
http://dx.doi.org/10.1083/jcb.200405167
_version_ 1782145027975151616
author Mikhailov, Alexei
Shinohara, Mio
Rieder, Conly L.
author_facet Mikhailov, Alexei
Shinohara, Mio
Rieder, Conly L.
author_sort Mikhailov, Alexei
collection PubMed
description When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells with hyperosmotic medium or a histone deacetylase inhibitor similarly delays entry into mitosis, and this delay can also be prevented by inhibiting p38. Together, these results reveal that agents or stresses that induce global changes in chromatin topology during G2 delay entry into mitosis, independent of the ATM-mediated DNA damage checkpoint, by activating the p38 MAPK checkpoint. The presence of this pathway obviates the necessity of postulating the existence of multiple “chromatin modification” checkpoints during G2. Lastly, cells that enter mitosis in the presence of topo II inhibitors form metaphase spindles that are delayed in entering anaphase via the spindle assembly, and not the p38, checkpoint.
format Text
id pubmed-2172207
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21722072008-03-05 Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway Mikhailov, Alexei Shinohara, Mio Rieder, Conly L. J Cell Biol Research Articles When early prophase PtK(1) or Indian muntjac cells are exposed to topoisomerase II (topo II) inhibitors that induce little if any DNA damage, they are delayed from entering mitosis. We show that this delay is overridden by inhibiting the p38, but not the ATM, kinase. Treating early prophase cells with hyperosmotic medium or a histone deacetylase inhibitor similarly delays entry into mitosis, and this delay can also be prevented by inhibiting p38. Together, these results reveal that agents or stresses that induce global changes in chromatin topology during G2 delay entry into mitosis, independent of the ATM-mediated DNA damage checkpoint, by activating the p38 MAPK checkpoint. The presence of this pathway obviates the necessity of postulating the existence of multiple “chromatin modification” checkpoints during G2. Lastly, cells that enter mitosis in the presence of topo II inhibitors form metaphase spindles that are delayed in entering anaphase via the spindle assembly, and not the p38, checkpoint. The Rockefeller University Press 2004-08-16 /pmc/articles/PMC2172207/ /pubmed/15302851 http://dx.doi.org/10.1083/jcb.200405167 Text en Copyright © 2004, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Research Articles
Mikhailov, Alexei
Shinohara, Mio
Rieder, Conly L.
Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
title Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
title_full Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
title_fullStr Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
title_full_unstemmed Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
title_short Topoisomerase II and histone deacetylase inhibitors delay the G2/M transition by triggering the p38 MAPK checkpoint pathway
title_sort topoisomerase ii and histone deacetylase inhibitors delay the g2/m transition by triggering the p38 mapk checkpoint pathway
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2172207/
https://www.ncbi.nlm.nih.gov/pubmed/15302851
http://dx.doi.org/10.1083/jcb.200405167
work_keys_str_mv AT mikhailovalexei topoisomeraseiiandhistonedeacetylaseinhibitorsdelaytheg2mtransitionbytriggeringthep38mapkcheckpointpathway
AT shinoharamio topoisomeraseiiandhistonedeacetylaseinhibitorsdelaytheg2mtransitionbytriggeringthep38mapkcheckpointpathway
AT riederconlyl topoisomeraseiiandhistonedeacetylaseinhibitorsdelaytheg2mtransitionbytriggeringthep38mapkcheckpointpathway